No Data
Hong Kong stock announcements to capitalize on | Baidu Group-SW reported a net income of 7.717 billion yuan in the first quarter, an increase of 41.65% year-on-year.
SSY GROUP (02005): Obtained the production registration approval from the National Medical Products Administration for hydrochloride denosumab tablets (400mg) and injectable methylsulfonylmethane (0.1g); INNOCARE (09969): The National Medical Products Administration approved the combination treatment of MINJUVI (TAFASITAMAB) with lenalidomide for adult patients in China with relapsed or refractory diffuse large B-cell lymphoma.
SSY Gets China Nod for Production, Registration of Antiarrhythmic Drug
SSY GROUP (02005): Obtained the drug production registration certificate from the National Medical Products Administration for hydrochloride duratone tablets (400mg) and injection use of methanesulfonic acid gabexate (0.1g).
SSY GROUP (02005) announced that the group has obtained the relevant approval from the National Medical Products Administration of China for Ondansetron Hydrochloride...
SSY Group Gains Approval for New Pharmaceutical Products in China
Stone Four Pharmaceutical (02005.HK) has received production registration approval for a new type of anti-arrhythmia drug.
Stone Four Pharma (02005.HK) announced that it has obtained the production registration approval from the National Medical Products Administration for Dronedarone Hydrochloride Tablets (400mg), classified as Category 4 chemical drugs, which is considered to have passed the consistency evaluation. Dronedarone Hydrochloride Tablets are a new type of antiarrhythmic drug primarily used to reduce the risk of hospitalization due to atrial fibrillation in patients with a history of paroxysmal or persistent atrial fibrillation. Additionally, the group has obtained the production registration approval from the National Medical Products Administration for injection of Methylsulfonylmethane (0.1g), classified as Category 3 chemical drugs, which is also considered to have passed the consistency evaluation. The injection of Methylsulfonylmethane is mainly
The concepts of new consumption and mergers and acquisitions remain hot! Grasping the rotation opportunities with the continuous warming of short-term sentiment may be the key.
Yesterday, the overall market continued its fluctuating and differentiated trend, with short-term speculative sentiment warming up persistently, and both the North Securities 50 and the Micro-Plate stock Index reached new historical highs.
